Patterns of clinical presentation in Takayasu's arteritis.


Journal

Seminars in arthritis and rheumatism
ISSN: 1532-866X
Titre abrégé: Semin Arthritis Rheum
Pays: United States
ID NLM: 1306053

Informations de publication

Date de publication:
08 2020
Historique:
received: 07 02 2020
revised: 27 04 2020
accepted: 29 04 2020
pubmed: 28 5 2020
medline: 14 7 2021
entrez: 28 5 2020
Statut: ppublish

Résumé

Takayasu's arteritis (TAK) is a clinically heterogenous disease. Patterns of clinical presentation in TAK at diagnosis have not been well described, and a "triphasic pattern" of constitutional symptoms evolving into vascular inflammation and fibrosis has been reported but never systematically evaluated. Patients with TAK were prospectively recruited from the National Institutes of Health (NIH) and the Vasculitis Clinical Research Consortium (VCRC). Based on clinical presentation at diagnosis, patients were divided into five categories: (1) constitutional symptoms alone, (2) carotidynia, (3) other vascular-associated symptoms, (4) major ischemic event, or (5) asymptomatic. Associated clinical characteristics were evaluated in each category. Preceding symptoms were also assessed to determine the presence of a triphasic disease pattern. A total of 275 patients with TAK were included (VCRC=208; NIH=67). Similar heterogeneity of clinical presentation was identified in each cohort: constitutional symptoms (8%), carotidynia (13-15%), other vascular symptoms (43-47%), major ischemic event (28-30%), and asymptomatic (2-6%). An increased relative proportion of males was seen in patients who presented with constitutional symptoms or were asymptomatic at diagnosis (p<0.01). Patients who presented with constitutional symptoms and major ischemic events were youngest at diagnosis. Patients in the asymptomatic group were oldest at diagnosis and often were not treated (p<0.01). Relapse was most frequent in patients who presented with carotidynia (p<0.01). A minority of patients (19%) who presented with a major ischemic event reported a triphasic pattern of disease. There are diverse clinical presentations at diagnosis in TAK. Patients do not necessarily progress sequentially through phases of disease.

Identifiants

pubmed: 32460147
pii: S0049-0172(20)30126-8
doi: 10.1016/j.semarthrit.2020.04.012
pii:
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

576-581

Subventions

Organisme : NIAMS NIH HHS
ID : U54 AR057319
Pays : United States
Organisme : NCRR NIH HHS
ID : U54 RR019497
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Kaitlin A Quinn (KA)

Division of Rheumatology, MedStar Georgetown University Hospital, Washington DC, USA; Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD, USA. Electronic address: Kaitlin.quinn@nih.gov.

K Bates Gribbons (KB)

Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD, USA.

Simon Carette (S)

Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, CA.

David Cuthbertson (D)

Department of Biostatistics, University of South Florida, Tampa, FL, USA.

Nader A Khalidi (NA)

Division of Rheumatology, McMaster University, Hamilton, CA.

Curry L Koening (CL)

Division of Rheumatology, University of Utah, Salt Lake City, UT, USA.

Carol A Langford (CA)

Department of Rheumatic and Immunologic Diseases, Cleveland Clinic Foundation, Cleveland, OH, USA.

Carol A McAlear (CA)

Division of Rheumatology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA.

Paul A Monach (PA)

Division of Rheumatology, VA Boston Healthcare System, Boston, MA, USA.

Larry W Moreland (LW)

Division of Rheumatology, University of Pittsburgh, PA, USA.

Christian Pagnoux (C)

Division of Rheumatology, Mount Sinai Hospital, University of Toronto, Toronto, CA.

Philip Seo (P)

Division of Rheumatology, Johns Hopkins University, MD, USA.

Antoine G Sreih (AG)

Division of Rheumatology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA.

Kenneth J Warrington (KJ)

Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.

Steven R Ytterberg (SR)

Division of Rheumatology, Mayo Clinic, Rochester, MN, USA.

Elaine Novakovich (E)

Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD, USA.

Peter A Merkel (PA)

Division of Rheumatology, Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania, Philadelphia, PA, USA.

Peter C Grayson (PC)

Systemic Autoimmunity Branch, National Institutes of Health, NIAMS, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH